Literature DB >> 3183474

Mortality from colorectal and breast cancer in gastric-surgery patients.

C P Caygill1, M J Hill, J S Kirkham, T C Northfield.   

Abstract

In a preliminary "years at risk" analysis of 5018 patients treated surgically for peptic ulcer at St. James Hospital, Balham, between 1940 and 1960, there was an increase in mortality from colorectal cancer 20 or more years after operation (1.6 fold; p less than 0.05) and an increase in mortality from breast cancer (4.0 fold; p less than 0.001). During the first 20 post-operative years there was an apparent decrease in mortality from both cancers (relative rate = 0.7 (NS) for colorectal and 0.5 (p less than 0.01), for breast cancer). The excess risk of colorectal cancer after a 20 year latency was almost entirely due to the 9.5 fold (p less than 0.001) excess risk in the 381 female gastric ulcer patients treated by Billroth I operation, and the 8.0 fold (p less than 0.05) excess mortality for the small group of 123 female patients who had vagotomy for duodenal ulcer. The apparent decreased risk during the first 20 post-operative years was entirely due to the 5-fold decrease (p less than 0.01) in risk in the 659 male patients treated by Billroth I surgery for gastric ulcer. The ratio of colon: rectal cancers was very much higher in gastric ulcer than in duodenal ulcer patients (5.6 compared to 1.8) and higher in females than in males (6.0 compared to 2.4). The excess risk of breast cancer after a 20 year latency was 4-fold in both gastric ulcer and duodenal ulcer patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3183474     DOI: 10.1007/bf01648356

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  14 in total

Review 1.  Etiology of human breast cancer: a review.

Authors:  B MacMahon; P Cole; J Brown
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

2.  Incidence of multiple primary cancers. II. Index cancers arising in the stomach and lower digestive system.

Authors:  D Schottenfeld; J W Berg; B Vitsky
Journal:  J Natl Cancer Inst       Date:  1969-07       Impact factor: 13.506

3.  Occurrence of certain multiple primary cancers in females.

Authors:  B S Schoenberg; R A Greenberg; H Eisenberg
Journal:  J Natl Cancer Inst       Date:  1969-07       Impact factor: 13.506

4.  Mortality from gastric cancer following gastric surgery for peptic ulcer.

Authors:  C P Caygill; M J Hill; J S Kirkham; T C Northfield
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

5.  Mortality from carcinoma after partial gastrectomy.

Authors:  K Inokuchi; S Tokudome; M Ikeda; M Kuratsune; H Ichimiya; N Kaibara; T Ikejiri; N Oka
Journal:  Gan       Date:  1984-07

6.  Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study.

Authors:  J D Potter; A J McMichael
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

7.  Late mortality after surgery for peptic ulcer.

Authors:  A H Ross; M A Smith; J R Anderson; W P Small
Journal:  N Engl J Med       Date:  1982-08-26       Impact factor: 91.245

8.  Fecal steroid metabolites and breast cancer risk.

Authors:  A E Papatestas; D Panvelliwalla; P I Tartter; S Miller; D Pertsemlidis; A H Aufses
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

9.  Gastric surgery and the risk of subsequent colorectal cancer.

Authors:  N J Bundred; B C Whitfield; E Stanton; R J Prescott; G C Davies; A N Kingsnorth
Journal:  Br J Surg       Date:  1985-08       Impact factor: 6.939

10.  Environmental factors and cancer of the colon and breast.

Authors:  B S Drasar; D Irving
Journal:  Br J Cancer       Date:  1973-02       Impact factor: 7.640

View more
  2 in total

1.  Cancer occurrence in a cohort of patients surgically treated for peptic ulcer.

Authors:  H Møller; C Toftgaard
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

Review 2.  Neurobiology of cancer: Definition, historical overview, and clinical implications.

Authors:  Boris Mravec
Journal:  Cancer Med       Date:  2021-12-24       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.